Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Soft Tissue Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT01864109
What this trial is testing

Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma

Who this might be right for
Newly Diagnosed Ewing Sarcoma
Memorial Sloan Kettering Cancer Center 83
Not applicableLooking for participantsNCT06384404
What this trial is testing

Upfront Surgical Resection for Osteosarcoma

Who this might be right for
Osteosarcoma
Montefiore Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT00923351
What this trial is testing

Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma

Who this might be right for
NeuroblastomaSarcomaRhabdomyosarcoma-Embryonal+2 more
National Cancer Institute (NCI) 44
Not applicableStudy completedNCT03076333
What this trial is testing

PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Tx of High Grade Sarcomas

Who this might be right for
Sarcoma
UNC Lineberger Comprehensive Cancer Center 3
Early research (Phase 1)Study completedNCT00822848
What this trial is testing

Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma

Who this might be right for
Sarcoma
OHSU Knight Cancer Institute 18
Testing effectiveness (Phase 2)WithdrawnNCT04906876
What this trial is testing

9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas

Who this might be right for
SarcomaSoft Tissue SarcomaMetastatic Sarcoma+10 more
Brown University
Testing effectiveness (Phase 2)Ended earlyNCT00788125
What this trial is testing

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
City of Hope Medical Center 7
Early research (Phase 1)Ended earlyNCT04037527
What this trial is testing

Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the Extremities

Who this might be right for
Soft Tissue Sarcoma
Wake Forest University Health Sciences 9
Testing effectiveness (Phase 2)Study completedNCT00002526
What this trial is testing

Chemotherapy in Treating Patients With Advanced Sarcoma

Who this might be right for
Ovarian CancerSarcoma
Swiss Cancer Institute 20
Early research (Phase 1)Study completedNCT02484391
What this trial is testing

CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma

Who this might be right for
Granulocytic SarcomaRecurrent Adult Acute Myeloid Leukemia
Wake Forest University Health Sciences 48
Not applicableStudy completedNCT03245788
What this trial is testing

Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study

Who this might be right for
Breast CancerGynecologic CancerNeck Cancer+9 more
Stanford University 1,053
Early research (Phase 1)Looking for participantsNCT06156410
What this trial is testing

Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

Who this might be right for
Ewing SarcomaOsteosarcomaSarcomas
Children's Hospital of Philadelphia 30
Early research (Phase 1)Looking for participantsNCT06889766
What this trial is testing

NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma

Who this might be right for
Advanced MelanomaMelanoma MetastaticSarcoma
Centre Hospitalier Universitaire Vaudois 9
Early research (Phase 1)Active Not RecruitingNCT06014762
What this trial is testing

P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

Who this might be right for
Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedHigh-grade B-cell LymphomaPrimary Mediastinal Large B-cell Lymphoma (PMBCL)+7 more
Poseida Therapeutics, Inc. 120
Testing effectiveness (Phase 2)UnknownNCT03676985
What this trial is testing

A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Limited Stage of High-grade Osteosarcoma

Who this might be right for
Osteosarcoma
Lee's Pharmaceutical Limited 15
Large-scale testing (Phase 3)Temporarily pausedNCT05691478
What this trial is testing

Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

Who this might be right for
High Grade OsteosarcomaLocalized OsteosarcomaMetastatic Osteosarcoma+1 more
National Cancer Institute (NCI) 1,122
Not applicableLooking for participantsNCT05111964
What this trial is testing

HIFU Ablation of Soft Tissue Sarcoma

Who this might be right for
Soft Tissue SarcomaDesmoid Tumors
Oxford University Hospitals NHS Trust 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03373097
What this trial is testing

Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors

Who this might be right for
NeuroblastomaNeuroblastoma RecurrentGD2-positive Solid Tumors+3 more
Bambino Gesù Hospital and Research Institute 42
Testing effectiveness (Phase 2)Study completedNCT00004132
What this trial is testing

Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaLymphoma+3 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01283035
What this trial is testing

A Phase II Study of Akt Inhibitor MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer

Who this might be right for
Ovarian SarcomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian Carcinoma+1 more
National Cancer Institute (NCI) 6
Next Page